logo

Julphar Pharmaceutical Manufacturing Facility in Saudi Arabia

Sector: Manufacturing (Industrial) • Location: Jeddah, Saudi Arabia

Source: ZAWYA

Project
Planned

Julphar (Gulf Pharmaceutical Industries) has signed a long-term lease agreement to establish an integrated pharmaceutical manufacturing facility in the Kingdom of Saudi Arabia. The facility will localize pharmaceutical manufacturing, strengthen national health security, and serve as a regional hub for exporting pharmaceutical products to GCC countries and global markets. The project supports Saudi

Project Information FAQ

Project Information

4 Q
The project “Julphar Pharmaceutical Manufacturing Facility in Saudi Arabia” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Jeddah, Saudi Arabia. Taiyo aggregates data on it from ZAWYA.

Want to explore the full details? View the full report

Participants

Sponsoring Agency

Obfuscated Data

Company

Obfuscated Data

Status

Original status

planned

Taiyo status

Obfuscated Data

Taiyo last update

00-00-0000

Available timestamps

00-00-0000

Available timestamp type

Obfuscated Data

Contact

Contact name

Obfuscated Data

Phone

0000000000

Email

ObfuscatedData@email.com

Address

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description

Julphar (Gulf Pharmaceutical Industries) has signed a long-term lease agreement to establish an integrated pharmaceutical manufacturing facility in the Kingdom of Saudi Arabia. The facility will localize pharmaceutical manufacturing, strengthen national health security, and serve as a regional hub for exporting pharmaceutical products to GCC countries and global markets. The project supports Saudi Vision 2030 objectives through technology transfer, development of local industrial capabilities, and enhancement of self-sufficiency in the pharmaceutical sector. The facility will be developed on a land area of 45,000 square metres with a total investment of approximately SAR 300 million and is expected to generate up to 1,400 direct employment opportunities. It will deploy advanced manufacturing technologies covering sterile injectables and oral solid dosage forms, focusing on biologics and specialty pharmaceuticals.

Original sub-sector

Obfuscated

Original Currency

USD

Original budget

000000000000000

Procurement method

Obfuscated Data

Budget

000000000000000

Location

Region

Obfuscated

Country

Obfuscated

State

Obfuscated Data

County

Obfuscated

Location

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability

High

Data quality score

100%

Source

Obfuscated Data

URL

obfuscated_data,obfuscateddata.com

More Details

Project Type

Obfuscated Data

Article Published Date

Obfuscated Data